
Bionano Genomics (NASDAQ:BNGO) brought in sales totaling $5.70 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 30.52%, resulting in a loss of $29.95 million. Bionano Genomics collected $6.30 million in revenue during Q4, but reported earnings showed a $22.95 million loss.